Home/Filings/4/0001179110-21-007314
4//SEC Filing

Ryll Thomas 4

Accession 0001179110-21-007314

CIK 0000855654other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 4:18 PM ET

Size

4.9 KB

Accession

0001179110-21-007314

Insider Transaction Report

Form 4
Period: 2021-06-30
Ryll Thomas
VP, Technical Operations
Transactions
  • Award

    Common Stock

    2021-06-30$5.52/sh+3,849$21,24684,714 total
Footnotes (2)
  • [F1]These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2021 through June 30, 2021.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 4, 2021.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001701531

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 4:18 PM ET
Size
4.9 KB